Ignite Creation Date:
2024-05-06 @ 9:23 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02973737
Status:
UNKNOWN
Last Update Posted:
2022-10-25
First Post:
2016-11-22
Brief Title:
A Study of Pyrotinib Plus Capecitabine in Patients With HER2 Metastatic Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2 Positive Metastatic Breast Cancer |
Keywords: